Oncogene - Table of Contents alert Volume 37 Issue 18

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 37, Issue 18 In this issue Review Article Article Also new AOP Review Article Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis Mikael S. Lindström, Deana Jurada, Sladana Bursac, Ines Orsolic, Jiri Bartek et al. Oncogene 2018 37 :2351 - 2366; February 12, 2018; 10.1038/s41388-017-0121-z Abstract | Full Text Metabolic features of cancer stem cells: the emerging role of lipid metabolism Rita Mancini, Alessia Noto, Maria Elena Pisanu, Claudia De Vitis, Marcello Maugeri-Saccà et al. Oncogene 2018 37 :2367 - 2378; February 15, 2018; 10.1038/s41388-018-0141-3 Abstract | Full Text Article p53 isoforms regulate premature aging in human cells Natalia von Muhlinen, Izumi Horikawa, Fatima Alam, Kazunobu Isogaya, Delphine Lissa et al. Oncogene 2018 37 :2379 - 2393; February 12, 2018; 10.1038/s41388-017-0101-3 Abstract | Full Text SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-κB-CD47 axis Fei Liu, Miao Dai, Qinyang Xu, Xiaolu Zhu, Yang Zhou et al. Oncogene 2018 37 :2394 - 2409; February 12, 2018; 10.1038/s41388-017-0119-6 Abstract | Full Text Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt's lymphoma cells Justine Debernardi, Emilie Hollville, Marc Lipinski, Joëlle Wiels & Aude Robert Oncogene 2018 37 :2410 - 2421; February 14, 2018; 10.1038/s41388-018-0123-5 Abstract | Full Text The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization Lei Li, Tongzheng Liu, Yunhui Li, Chenming Wu, Kuntian Luo et al. Oncogene 2018 37 :2422 - 2431; February 16, 2018; 10.1038/s41388-018-0134-2 Abstract | Full Text Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression J. Lin, J.-C. Ma, J. Yang, J.-Y. Yin, X.-X. Chen et al. Oncogene 2018 37 :2432 - 2443; February 16, 2018; 10.1038/s41388-018-0146-y Abstract | Full Text Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C Vincent L. Cannataro, Stephen G. Gaffney, Carly Stender, Zi-Ming Zhao, Mark Philips et al. Oncogene 2018 37 :2444 - 2455; February 16, 2018; 10.1038/s41388-017-0105-z Abstract | Full Text Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-κB/IL-6/STAT3 axis Hualin Zhang, Yang Song, Huimin Yang, Zhiyan Liu, Lifen Gao et al. Oncogene 2018 37 :2456 - 2468; February 16, 2018; 10.1038/s41388-018-0140-4 Abstract | Full Text Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth Xia Li, Hongguang Ma, Lin Li, Yifan Chen, Xiao Sun et al. Oncogene 2018 37 :2469 - 2480; February 19, 2018; 10.1038/s41388-017-0076-0 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.